PL379831A1 - Coated tablet containing carbomer for extended release of indapamid, which release profile is adjusted exactly during the coating process - Google Patents

Coated tablet containing carbomer for extended release of indapamid, which release profile is adjusted exactly during the coating process

Info

Publication number: PL379831A1
Authority: PL; Poland
Prior art keywords: indapamid; coating process; coated tablet; tablet containing; release
Prior art date: 2006-06-02

Application number

PL379831A

Other languages

Polish (pl)

Other versions

PL204780B1 (en

Inventor

Malcolm Stewart Frank Ross

Jarosław Mazgalski

Original Assignee

Zakłady Farmaceutyczne POLPHARMA Spółka Akcyjna

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-06-02

Filing date

2006-06-02

Publication date

2007-12-10

2006-06-02 Application filed by Zakłady Farmaceutyczne POLPHARMA Spółka Akcyjna filed Critical Zakłady Farmaceutyczne POLPHARMA Spółka Akcyjna

2006-06-02 Priority to PL379831A priority Critical patent/PL204780B1/en

2007-06-01 Priority to EP07747745A priority patent/EP2023904A2/en

2007-06-01 Priority to PCT/PL2007/000036 priority patent/WO2007142546A2/en

2007-12-10 Publication of PL379831A1 publication Critical patent/PL379831A1/en

2010-02-26 Publication of PL204780B1 publication Critical patent/PL204780B1/en

Links

NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 title 1
229920002125 Sokalan® Polymers 0.000 title 1
229960001631 carbomer Drugs 0.000 title 1
238000000576 coating method Methods 0.000 title 1
238000013265 extended release Methods 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Inorganic Chemistry (AREA)
Emergency Medicine (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

PL379831A 2006-06-02 2006-06-02 Coated tablet containing carbomer for extended release of indapamid, which release profile is adjusted exactly during the coating process PL204780B1 (en)

Priority Applications (3)

Application Number	Priority Date	Filing Date	Title
PL379831A PL204780B1 (en)	2006-06-02	2006-06-02	Coated tablet containing carbomer for extended release of indapamid, which release profile is adjusted exactly during the coating process
EP07747745A EP2023904A2 (en)	2006-06-02	2007-06-01	Sustained release coated tablet with precisely regulated release profile
PCT/PL2007/000036 WO2007142546A2 (en)	2006-06-02	2007-06-01	Sustained release coated tablet with precisely regulated release profile

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
PL379831A PL204780B1 (en)	2006-06-02	2006-06-02	Coated tablet containing carbomer for extended release of indapamid, which release profile is adjusted exactly during the coating process

Publications (2)

Publication Number	Publication Date
PL379831A1 true PL379831A1 (en)	2007-12-10
PL204780B1 PL204780B1 (en)	2010-02-26

Family

ID=38786936

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL379831A PL204780B1 (en)	2006-06-02	2006-06-02	Coated tablet containing carbomer for extended release of indapamid, which release profile is adjusted exactly during the coating process

Country Status (3)

Country	Link
EP (1)	EP2023904A2 (en)
PL (1)	PL204780B1 (en)
WO (1)	WO2007142546A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2380561A1 (en) *	2010-04-21	2011-10-26	LEK Pharmaceuticals d.d.	Extended release formulation comprising indapamide
WO2020109319A1 (en)	2018-11-27	2020-06-04	Zaklady Farmaceutyczne Polpharma S.A	Pharmaceutical composition comprising ramipril and indapamide

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6156342A (en) *	1998-05-26	2000-12-05	Andex Pharmaceuticals, Inc.	Controlled release oral dosage form
US20020143058A1 (en) *	2001-01-24	2002-10-03	Taro Pharmaceutical Inductries Ltd.	Process for preparing non-hygroscopic sodium valproate composition
AU2003202879A1 (en) *	2002-01-04	2003-07-24	Ivax Research, Inc.	Drug delivery system for sustained delivery of glipizide
EP1589957A1 (en) *	2003-02-05	2005-11-02	IPCA Laboratories Limited	Pharmaceutical compositions and process of production thereof
DE102004005009A1 (en) *	2004-01-30	2005-09-01	Krka Tovarna Zdravil, D.D.	Delayed release pharmaceutical composition of indapamide

2006
- 2006-06-02 PL PL379831A patent/PL204780B1/en unknown
2007
- 2007-06-01 EP EP07747745A patent/EP2023904A2/en not_active Withdrawn
- 2007-06-01 WO PCT/PL2007/000036 patent/WO2007142546A2/en not_active Ceased

Also Published As

Publication number	Publication date
EP2023904A2 (en)	2009-02-18
WO2007142546A3 (en)	2008-02-21
WO2007142546A2 (en)	2007-12-13
PL204780B1 (en)	2010-02-26

Publication	Publication Date	Title
IL193879A (en)	2014-02-27	Flat process of drug coating for stents
ZA201200291B (en)	2012-09-26	Process for the preparation of a coated substrate, coated substrate, and use thereof
ZA201008097B (en)	2014-04-30	Process for the preparation of 2,3,3,3-trifluoropropene
ZA201007526B (en)	2014-03-26	Process for the preparation of 2,3,3,3-tetrafluoropropene
EP2158176A4 (en)	2011-11-09	Two step process for the manufacture of hydrofluoroolefins
PL2349962T3 (en)	2020-08-10	Process for the manufacture of hydrochlorofluoroolefins
PL2170785T3 (en)	2018-12-31	Process for the manufacture of hydrofluoroolefins
IL197081A0 (en)	2009-12-24	Radiation-selective absorber coating, absorber tube and process for production thereof
IL202046A0 (en)	2010-06-16	Process for the manufacture of p4o6
SG136929A1 (en)	2007-11-29	A method for the manufacture of a coating
IL220430A0 (en)	2012-07-31	Process for the production of benzopyran-2-ol derivatives
PL2193223T3 (en)	2017-06-30	Methods for coating a metal substrate
GB2451175B (en)	2013-03-06	Plasma coating of footwear
EP2226407A4 (en)	2015-04-08	Process for producing metal film, metal film and use of the metal film
IL205082A0 (en)	2010-11-30	Process for the preparation of tetranorlabdane derivatives
PL2102174T3 (en)	2017-09-29	Process for the preparation of substituted cynophenoxy-pyrimidinyloxy-phenyl acrylate derivatives
IL206571A0 (en)	2010-12-30	Process for the preparation of an enantiomeric triubstituted 3,4-dihydro-isoquinoline derivative
GB2460983B (en)	2012-05-02	A process for the preparation of ethanol from starch
IL205818A (en)	2016-05-31	Process for the preparation of film coated tablets containing drospirenone
IL193068A0 (en)	2009-02-11	Process for the stereoselective preparation of alcohols from alpha, beta-insaturated compounds
PL1884576T3 (en)	2013-02-28	Device for plasma coating of long, cylindrical components
IL206886A0 (en)	2010-12-30	Process for the manufacture of a 6-fluoro-1,2-dihydro-2-oxo-3h-indol-3-ylidene derivative
GB2468255B8 (en)	2016-11-16	Process for forming multilayered coating film
WO2012078574A9 (en)	2012-08-16	Janus kinase 2 (jak2) inhibitor for the treatment of lupus
EP2170902A4 (en)	2011-08-03	Improved processes for the synthesis of olanzapine